blood screening industry Overview

There is a consistent increase in the global blood screening industry which is anticipated to reach $5.07 billion by 2030 at a CAGR of 8.2%, similar to previous industry reports. As the demand for safe blood supply increases and the need for high-throughput screening processes becomes more critical, industry players are expanding their portfolios and entering into mergers and acquisitions and collaborations to stay ahead of the competition.

blood screening industry Key Leaders

Abbott Laboratories: Our company: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Their Alinity series is a portfolio of harmonized diagnostic systems that helps maximize operational efficiency by enabling different testing methodologies. Recent innovations from Abbott also include AI-enabled imaging software that improves coronary stenting procedures, as well as international partnerships with blood banks to ensure that they have access to the newest screening technologies.

Thermo Fisher Scientific, Inc.: Thermo Fisher Scientific is based in Waltham, Massachusetts, and offers an array of solutions across the pharmaceuticals, biotechnology, and clinical diagnostics domains. The company’s well-developed diagnostic systems facilitate the identification of pathogens, allergens, autoimmune disorders, and infectious agents. The company also has a microbiology division that developed rapid diagnostic tests that are used early on in critical care.

Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, founded in 1952, provides a range of innovative products for life sciences research and clinical diagnostics. Generating $2.7 billion dollars a revenue in 2023, Bio-Rad’s dual focus on life sciences and clinical diagnostics provides comprehensive data and information solutions for both scientific and medical needs.

Becton Dickinson and Company (BD): BD is a global leader in medical technology whose commitment to advancing the health of people worldwide through its laboratory diagnostic solutions and blood screening technologies.

Reqeust for free sample: https://www.maximizemarketresearch.com/request-sample/259166/

blood screening industry Sector News and Business Strategies

Abbott Laboratories: Created an artificial intelligence-enabled imaging software for coronary stenting procedures that combines optical coherence tomography with AI to enhance procedure accuracy.

Thermo Fisher Scientific: Added new diagnostic test systems for allergy, asthma, and autoimmune disease usage.

Bio-Rad Laboratories: Enhanced its position in the life sciences and clinical diagnostic segments through consistent innovation and growth.

blood screening industry Mergers and Acquisitions

Blood screening market has witnessed several consolidation acts wherein top companies acquire smaller companies to expand geographical presence and product offerings. Strategic Mergers & Acquisitions continue to redefine the competitive landscape for the service delivery.

About Us

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Us

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
[email protected]